JWH-193
JWH-193 is a drug from the aminoalkylindole and naphthoylindole families which acts as a cannabinoid receptor agonist. It was invented by the pharmaceutical company Sanofi-Winthrop in the early 1990s. JWH-193 has a binding affinity at the CB1 receptor of 6 nM, binding around seven times more tightly than the parent compound JWH-200, though with closer to twice the potency of JWH-200 in activity tests. In the United States, all CB1 receptor agonists of the 3-(1-naphthoyl)indole class such as JWH-193 are Schedule I Controlled Substances.
Wikipage disambiguates
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
JWH-193
JWH-193 is a drug from the aminoalkylindole and naphthoylindole families which acts as a cannabinoid receptor agonist. It was invented by the pharmaceutical company Sanofi-Winthrop in the early 1990s. JWH-193 has a binding affinity at the CB1 receptor of 6 nM, binding around seven times more tightly than the parent compound JWH-200, though with closer to twice the potency of JWH-200 in activity tests. In the United States, all CB1 receptor agonists of the 3-(1-naphthoyl)indole class such as JWH-193 are Schedule I Controlled Substances.
has abstract
JWH-193 is a drug from the ami ...... edule I Controlled Substances.
@en
CAS number
133438-58-1
FDA UNII code
WB1TIJ1IO9
PubChem
Wikipage page ID
31,076,802
page length (characters) of wiki page
Wikipage revision ID
984,231,904
Link from a Wikipage to another Wikipage
CAS number
ChemSpiderID
IUPAC name
legal CA
Schedule II
@en
legal DE
NpSG
@en
legal UK
Class B
@en
legal US
Schedule I
@en
PubChem
10,250,276
SMILES
c3cccc1c3cCc5c2ccccc2nCCN4CCOCC4
@en
StdInChIKey
ICKWPPYMDARCKJ-UHFFFAOYSA-N
@en
UNII
WB1TIJ1IO9
@en
verifiedrevid
451,605,875
wikiPageUsesTemplate
subject
hypernym
comment
JWH-193 is a drug from the ami ...... edule I Controlled Substances.
@en
label
JWH-193
@en